Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 3
2010 1
2011 2
2012 10
2013 4
2014 4
2015 8
2016 8
2017 10
2018 9
2019 7
2020 10
2021 10
2022 6
2023 2
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. Choueiri TK, et al. Among authors: poprach a. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. N Engl J Med. 2024. PMID: 39167807 Clinical Trial.
Meigs syndrome.
Kristková L, Zvaríková M, Bílek O, Dufek D, Poprach A, Holánek M. Kristková L, et al. Among authors: poprach a. Klin Onkol. 2022 Spring;35(3):232-234. doi: 10.48095/ccko2022232. Klin Onkol. 2022. PMID: 35760576 English.
Oligometastatic Prostate Cancer.
Navrátil J, Poprach A, Lakomý R, Kocák I, Vašina J, Krupa P, Vyzula R. Navrátil J, et al. Among authors: poprach a. Klin Onkol. 2019 Spring;32(2):97-100. doi: 10.14735/amko201997. Klin Onkol. 2019. PMID: 30995848 Review. English.
[Immunotherapy of Renal Cell Carcinoma].
Poprach A, Lakomý R, Büchler T. Poprach A, et al. Klin Onkol. 2017 Winter;30(Supplementum3):55-61. doi: 10.14735/amko20173S55. Klin Onkol. 2017. PMID: 29239194 Review. Czech.
Long non-coding RNAs and renal cell carcinoma.
Fedorko M, Febu, Bohušová J, Poprach A, Pacík D. Fedorko M, et al. Among authors: poprach a. Klin Onkol. 2020 Spring;33(5):340-349. doi: 10.14735/amko2020340. Klin Onkol. 2020. PMID: 33108878 Review. English.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Incorvaia L, Monteiro FSM, Massari F, Park SH, Roviello G, Fiala O, Myint ZW, Kucharz J, Molina-Cerrillo J, Santini D, Buttner T, Poprach A, Kopecky J, Zeppellini A, Pichler M, Buchler T, Pichler R, Facchini G, Fay AP, Soares A, Manneh R, Iezzi L, Kuronya Z, Russo A, Bourlon MT, Bhuva D, Ansari J, Kanesvaran R, Grande E, Buti S, Santoni M. Incorvaia L, et al. Among authors: poprach a. Cancer Immunol Immunother. 2024 Jun 4;73(8):142. doi: 10.1007/s00262-024-03719-0. Cancer Immunol Immunother. 2024. PMID: 38832989 Free PMC article.
99 results